Filing Details
- Accession Number:
- 0001179110-10-012028
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-07-30 13:00:00
- Reporting Period:
- 2010-07-28
- Filing Date:
- 2010-07-30
- Accepted Time:
- 2010-07-30 16:51:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1142596 | Nuvasive Inc | NUVA | Surgical & Medical Instruments & Apparatus (3841) | 330768598 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1345767 | P Jeffrey Rydin | 7475 Lusk Blvd. San Diego CA 92121 | Evp, Sales, Americas | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-07-28 | 3,000 | $23.24 | 3,713 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-07-28 | 3,000 | $36.25 | 713 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2010-07-28 | 4,069 | $17.91 | 4,782 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-07-28 | 4,069 | $36.25 | 713 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2010-07-28 | 3,000 | $0.00 | 3,000 | $23.24 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2010-07-28 | 4,069 | $0.00 | 4,069 | $17.91 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
52,067 | 2017-01-16 | No | 4 | M | Direct | |
0 | 2009-12-05 | 2015-12-05 | No | 4 | M | Direct |
Footnotes
- The shares sold were acquired contemporaneously upon the cashless exercise of a stock option at an exercise price of $23.24 per share.
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13,2009.
- Includes the sale of 640 shares on May 26, 2010 and 1,274 shares on July 28, 2010 by the Reporting Person that were acquired through the Issuer's Employee Stock Purchase Plan. Both the purchase and subsequent sale of these shares are exempt from reporting under Section 16b-3.
- The shares sold were acquired contemporaneously upon the cashless exercise of a stock option at an exercise price of $17.91 per share.
- 25% of the total shares subject to the option vested on January 16, 2008 which was the first anniversary of the date of the grant; the remaining shares vest in 36 equal monthly installments thereafter.